Onward Medical N.V. (EBR:ONWD)
Belgium · Delayed Price · Currency is EUR 3.100
+0.100 (3.33%)
Apr 10, 2026, 5:37 PM CET
Onward Medical Revenue
In the year 2025, Onward Medical had annual revenue of 5.41M EUR with 211.33% growth. Onward Medical had revenue of 4.23M in the half year ending December 31, 2025.
Revenue
5.41M
Revenue Growth
+211.33%
P/S Ratio
32.07
Revenue / Employee
52.56K
Employees
103
Market Cap
173.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.41M | 3.68M | 211.33% |
| Dec 31, 2024 | 1.74M | 1.21M | 226.88% |
| Dec 31, 2023 | 532.00K | -1.62M | -75.23% |
| Dec 31, 2022 | 2.15M | 749.00K | 53.54% |
| Dec 31, 2021 | 1.40M | 599.00K | 74.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 3.61B |
| European Medical Solutions | 49.47M |
| Hyloris Pharmaceuticals | 8.83M |
| Celyad Oncology | 21.00K |
| Financière de Tubize | 13.26K |
| Oxurion NV | 2.00K |
| BioSenic | -2.39M |
Onward Medical News
- 11 days ago - ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions - GlobeNewsWire
- 11 days ago - Onward Medical NV (ONWRF) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 11 days ago - Full Year 2025 ONWARD Medical NV Earnings Call & Business Update Transcript - GuruFocus
- 12 days ago - ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones - GlobeNewsWire
- 20 days ago - ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update - GlobeNewsWire
- 2 months ago - ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury - GlobeNewsWire
- 2 months ago - ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement - GlobeNewsWire
- 4 months ago - ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025 - GlobeNewsWire